Jonathan M Peacock
CIK 1500241 · President and CEO · last filed 2025-05-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$35.60M
Companies
5
Total Filings
39
Lifetime Open-Market Net
$1.00M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVTR | Director | 219,815 | $9.39 | $2.06M | $103.6K | 4 | 2025-05-12 |
| Avantor, Inc. (AVTRpA) Delisted | Director | 176,339 | $90.81 | $16.01M | $0 | 5 | 2022-05-16 |
| Bellerophon Therapeutics, Inc. (BLPH) Delisted | Director | 157,033 | $0.01 | $1.9K | $900.1K | 18 | 2021-04-02 |
| Kite Pharma, Inc. (KITE) Delisted | Director | 70,374 | — | — | $0 | 3 | 2017-06-22 |
| AMGN | EVP & CFO | 94,414 | $355.20 | $33.54M | $0 | 8 | 2013-10-29 |
Recent Filings · Page 2 of 4
39 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-05-23 | Avantor, Inc. (AVTRpA) Delisted | Mixed | +132,143 | $0 | EDGAR |
| 2019-05-22 | Bellerophon Therapeutics, Inc. (BLPH) Delisted | Buy (P) | +20,000 | $12.2K | EDGAR |
| 2019-01-25 | Bellerophon Therapeutics, Inc. (BLPH) Delisted | Grant (A) | +227,273 | $0 | EDGAR |
| 2019-01-25 | Bellerophon Therapeutics, Inc. (BLPH) Delisted | Buy (P) | +714,286 | $500.0K | EDGAR |
| 2018-04-03 | Bellerophon Therapeutics, Inc. (BLPH) Delisted | Grant (A) | +99,010 | $0 | EDGAR |
| 2017-10-05 | — | Mixed | −70,374 | -$12.23M | |
| 2017-10-03 | Bellerophon Therapeutics, Inc. (BLPH) Delisted | Buy (P) | +248,962 | $0 | EDGAR |
| 2017-09-26 | Bellerophon Therapeutics, Inc. (BLPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-30 | Bellerophon Therapeutics, Inc. (BLPH) Delisted | Grant (A) | +57,972 | $0 | EDGAR |
| 2017-06-22 | Kite Pharma, Inc. (KITE) Delisted | Grant (A) | +2,410 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.